Seems cheap to me for what we have.We are talking pharmas with billions lying around.
"Celtic spelling" -very witty I'm sure...
I thoroughly agree-15$ a share would be "chump change" for a company such as Gilead with a sharevalue of over 30 Billion.
I don't think Gilead is very interested in Smallpox. They actually licensed out the smallpox rights for Cidofovir to Chimerix, which modified it to form a compound called CMX001.I'm not saying a takeover is not possible. I just don't think it will be Gilead. I wouldn't be surprised if Transtech Pharma came in with a M/A deal.